White Paper

A Sleeping Giant No More: Opportunities & Challenges For Clinical Research In China

Source: Thermo Fisher Scientific
A Sleeping Giant No More: Opportunities & Challenges For Clinical Research In China

This paper examines the opportunities and challenges of conducting clinical trials in China, and offers proven strategies for overcoming hurdles.

When Napoleon made his prescient observation two centuries ago, he could not have imagined how right he would be.

China awakened in the 21st Century as a global superpower, fueled by robust economic growth and a population so huge that it exceeds that of the entire world during Napoleon’s turbulent lifetime. Today, China’s determined leadership and pool of billion-plus potential patients have made their country one of the most desirable biopharmaceutical markets in the world and the top-ranked offshore site for conducting clinical trials.